Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years

Aim. To study the relationship of blood pressure (BP) and heart rate (HR) in a sample of men and women 25-64 years old and their predictive value for the development of fatal and non-fatal cardiovascular diseases (CVD) and mortality from all causes.

Material and methods. Prospective observation was for cohorts of the population aged 25-64 years from 11 regions of the Russian Federation. 18,251 people were included in the analysis. Each participant gave written informed consent. All surveyed persons were interviewed with a standard questionnaire. BP was measured on the right hand with an automatic tonometer. BP and HR were measured twice with an interval of 2-3 min with the calculation of the average value. The patients were divided into 4 groups: the first group with BP<140/90 ><140/90 mm Hg and HR≤80 beats/min; the second group – BP<140/><140/90 mm Hg and HR>80; the third group – BP≥140/90 mm Hg and HR≤80; the fourth group – BP≥140/90 mm Hg and HR>80 beats/min. Risk factors and cardiovascular history were analyzed as well. Deaths over 6 years of follow-up occurred in 393 people (141 – from CVD). Statistical analysis was performed using the open source R3.6.1 system.

Results. A HR>80 beats/min was found in 26.3% of people with BP≥140/90 mm Hg, regardless of medication. Analysis of the associations between HR and BP showed that for every increase in HR by 10 beats/min, systolic BP increases by 3 mm Hg. (p<0.0001). The group with HR>80 beats/min and BP≥140/90 mm Hg had the shortest life expectancy (p<0.001). Adding an increased HR to BP≥140/90 mm Hg significantly><0.001). Adding an increased HR to BP≥140/90 mm Hg significantly worsened the prognosis of patients. Similar results were obtained in the analysis of cardiovascular survival. Elevated BP and elevated HR had the same effect on outcomes, except for the combined endpoint, where the contribution of elevated BP was predominant. However, their combined effect was the largest and highly significant for the development of the studied outcomes, even after adjusting for other predictors. With an increase in HR by every 10 beats/min, the risk of mortality increased statistically significantly by 22%.

Conclusion. The prevalence of HR>80 beats/min in people with BP≥140 mm Hg amounted to 26.34%. Every 10 beats/min significantly increases the risk of mortality by 22%. Increased HR with elevated BP leads to increased adverse outcomes.

1. Flint A.C., Conell C., Ren X., et al. Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes. N Engl J Med. 2019;381(3):243. DOI:10.1056/NEJMoa1803180.

2. Huffman M.D., Lloyd-Jones D.M. Global burden of raised blood pressure: Coming into focus. JAMA. 2017;317:142. DOI:10,1001/jama.2016.19685.

3. 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) Eur Heart J. 2018;39:3021-104. DOI:10,1093/eurheartj/ehy33.

4. Heidenreich P.A., Trogdon J.G., Khavjou O.A., et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association. Circulation. 2011;123:933-44. DOI:10.1161/CIR.0b013e31820a55f5.

5. Boytsov S.A., Balanova Y.A., Shalnova S.A., et al. Arterial hypertension among individuals of 25-64 year old: prevalence, awareness, treatment and control. By the data from ESSD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14 (In Russ.) DOI:10.15829/1728-8800-2014-4-4-14.

6. Gillman M.W., Kannel W.B., Belanger A., D’Agostino R.B. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J. 1993;125(4):1148-54. DOI:10.1016/0002-8703(93)90128-v

7. Levy R.L., White P.D., Strod W.D.. et al. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA. 1945;129:585-8.

8. Palatini P. Role of Elevated Heart Rate in the Development of Cardiovascular Disease in Hypertension. J Hypertens. 2011;58:745-50. DOI:10.1161/HYPERTENSIONAHA.111.173104.

9. Julius S., Palatini P., Kjeldsen S.E., et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J of Cardiol. 2012;109(5):685-92. DOI:10.1016/j.amjcard.2011.10.025.

10. Okin P.M., Kjeldsen S.E., Julius S., et al. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. Eur Heart J. 2010;31(18):2271-9. DOI:10.1093/eurheartj/ehq225.

11. Kolloch R., Legler U.F., Champion A., et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: Findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J. 2008;29(10):1327-34. DOI:10.1093/eurheartj/ehn123.

12. Böhm M., Swedberg K., Komajda M., et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376(9744):886-94. DOI:10.1016/S0140-6736(10)61259-7.

13. Shalnova S.A., Deev A.D., Oganov R.G. Factors influencing cardiovascular mortality in russian population. Cardiovascular Therapy and Prevention 2005;4(1):4-9 (In Russ.)

14. Shalnova S.А., Deev A.D., Belova O.A., et al. Heart rate and its association with the main risk factors in the population of men and women of working age. Rational Pharmacotherapy in Cardiology 2017;13(6):819-26 (In Russ.) DOI:10.20996/1819-6446-2017-13-6-819-826.

15. Shabalin V.V., Grinshtein Y.I., Ruf R.R., Shtrikh A.Yu. Interrelations between heart rate, hypertension, and the other cardiovascular risk factors in Krasnoyarsk Krai population. The Siberian Journal of Clinical and Experimental Medicine. 2019;34(3):179-85 (In Russ.) DOI:10.29001/2073-8552-2019-34-3-179-185.

16. Rogowski O., Steinvil A., Berliner S., et al. Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabet. 2009;8:55. DOI:10.1186/1475-2840-8-55.

17. Schroeder E.B., Chambless L.E., Liao D., et al. Diabetes, glucose, insulin, and heart rate Variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005;28(3):668-74. DOI:10.2337/diacare.28.3.668.

18. Farinaro E., Stranges S., Guglielmucci G., et al. Heart rate as a risk factor in hypertensive individuals: the Italian TensioPulse Study. Nutr Metab Cardiovasc Dis. 1999;9:196-202.

19. Palatini P., Dorigatti F., Zaetta V. et al. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens. 2006;24:1873-80. DOI:10.1097/01.hjh.0000242413.96277.5b.

20. Vazir A., Claggett B., Cheng S., et al. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiol. 2018;3(3):200-6. DOI:10.1001/jamacardio.2017.4974.

21. Dalal J., Dasbiswas A., Sathyamurthy I., et al. Heart Rate in Hypertension: Review and Expert Opinion. Int J Hypertens. 2019;2019:2087064. DOI:10.1155/2019/2087064.

22. Zhang D., Shen X., Qi X. Resting Heart Rate and all cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ. 2016;188(3):E53-63. DOI:10.1503/cmaj.150535.

23. Raisi-Estabragh Z., Cooper J., Judge R., et al. Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK. PLoS ONE. 2020;15(5):e0233898. DOI:10,1371/journal.pone.0233898.